Rogelio Martinez Jr, MS

Rogelio Martinez Jr. provides technical, scientific, and regulatory support for pharmacology and toxicology projects in multiple therapeutic areas.  He provides support for outsourcing and study monitoring activities, nonclinical project management, and authoring nonclinical regulatory submission documents for Investigational New Drug Applications (INDs) and New Drug Applications (NDAs).  In addition, he has expertise in Standard for Exchange of Nonclinical Data (SEND) requirements, authoring primary and secondary pharmacology reports, and performs data and editorial quality control reviews of various nonclinical documents.  He understands the regulatory submission process to the United States Food and Drug Administration (FDA) and can assist in the formatting, processing, and quality control review of electronic submissions for filing to FDA.  Rogelio has a B.S. in Biology from Newman University and a M.S. in Pharmacology and Toxicology from Michigan State University.